In 249 patients with AF and recent ischaemic stroke, adding catheter ablation to standard therapy did not significantly reduce the composite of stroke, embolism, death or heart failure admission (5.6% vs 4.9% per person-year; HR 1.11); the trial was likely underpowered.
RCTn = 249 patients
Kimura et al. Catheter Ablation and Oral Anticoagulation for Secondary Stroke Prevention in Atrial Fibrillation: The STABLED Randomized Clinical Trial